Science
Decades of source-country research, near-zero independent replication: how to weigh geographically concentrated evidence.
Epitalon presents an evidence-evaluation puzzle: a large body of research from a single institutional lineage, with striking claims about telomerase and lifespan, and almost no independent replication attempts in Western literature.
This is not automatically disqualifying — but unreplicated geographically concentrated evidence warrants the Limited grade in our evidence taxonomy, and readers should understand why the distinction matters more here than citation counts.
Interim results from the TRIUMPH program suggest the triple agonist maintains its lead over dual-incretin therapy on weight and liver-fat endpoints.
ResearchAngiogenesis modulation, growth-factor signaling, and the gaps between rodent data and human claims.
ScienceSURMOUNT-5 and real-world cohorts consistently favor the dual agonist on weight endpoints — with nuances the headlines skip.
ResearchThe Peptide Institute Weekly
One email a week: new study summaries, the latest independent lab results, ranking movements, and regulatory developments that matter.
